The management of dyslipidemia in a private health care setting : a managed pharmaceutical care approach / Susan Mothekoa Bopape
The global anti-dyslipidemic market grew by 19% from 2000 to 2001, achieving sales of over $21 billion (Smith, 2004: 2). This market is currently well sewed by a number of effective and well-tolerated treatments. Lipid-lowering drugs are considered as the first choice drugs in control of dyslipidemi...
| Main Author: | |
|---|---|
| Published: |
North-West University
2009
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10394/483 |